MARKET

AMRN

AMRN

Amarin
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.980
+0.980
+24.50%
Pre Market: 5.24 +0.26 +5.22% 04:36 04/02 EDT
OPEN
4.020
PREV CLOSE
4.000
HIGH
5.29
LOW
4.000
VOLUME
97.80M
TURNOVER
--
52 WEEK HIGH
26.12
52 WEEK LOW
3.950
MARKET CAP
1.94B
P/E (TTM)
-71.1429
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 12 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average AMRN stock price target is 17.36 with a high estimate of 51.00 and a low estimate of 4.000.

EPS

AMRN News

More
  • 10 Biotech Winners And Losers In Q1
  • Benzinga · 12h ago
  • Amarin jumps 18% on possible patent win
  • Seeking Alpha - Article · 14h ago
  • Judges Record Looks Unpromising for Amarins Appeal; Analyst Remains Bullish
  • TipRanks · 16h ago
  • Citigroup Maintains Buy on Amarin Corp, Lowers Price Target to $6
  • Benzinga · 16h ago

Industry

Biotechnology & Medical Research
-4.52%
Pharmaceuticals & Medical Research
-2.91%

Hot Stocks

Symbol
Price
%Change

About AMRN

Amarin Corporation plc is a biopharmaceutical company with operations in lipid science focused on the commercialization and development of therapeutics for cardiovascular health. The Company operates through the development and commercialization of Vascepa segment. The Company's lead product, Vascepa (icosapent ethyl) capsule, is approved by the United States Food and Drug Administration (FDA) for use as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.
More

Webull offers kinds of Amarin Corporation plc (ADR) stock information, including NASDAQ:AMRN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMRN stock news, and many more online research tools to help you make informed decisions.